𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Can NK cells be a therapeutic target in human diseases?

✍ Scribed by Christopher J. Chan; Daniel M. Andrews; Mark J. Smyth

Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
168 KB
Volume
38
Category
Article
ISSN
0014-2980

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Our current knowledge of NK‐cell recognition and effector function suggests that it will be possible to design various new NK‐cell‐based immunotherapies against human cancer. The application of NK cells is already showing promise using HLA‐mismatched haematopoietic stem cell transplantation for treatment of haematological malignancies. A better understanding of NK‐cell heterogeneity and function will only broaden the applications for human cancer. Here we review the key developments that will propel this field.

📜 SIMILAR VOLUMES

Can NK cells be a therapeutic target in
Can NK cells be a therapeutic target in human type 1 diabetes?
✍ Francesco Dotta; Cecilia Fondelli; Alberto Falorni 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

## Abstract Type 1 diabetes is caused by the autoimmune destruction of insulin‐producing cells with consequent hyperglycemia and serious chronic complications. Both innate and adaptive immune responses participate in disease pathogenesis. Studies in animal models and in man have shown that NK cells

Bcl-XL is a chemoresistance factor in hu
Bcl-XL is a chemoresistance factor in human melanoma cells that can be inhibited by antisense therapy
✍ Elisabeth Heere-Ress; Christiane Thallinger; Trevor Lucas; Hermine Schlagbauer-W 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 195 KB

Malignant melanoma is a tumor that responds poorly to a variety of apoptosis-inducing treatment modalities, such as chemotherapy. The expression of genes that regulate apoptotic cell death plays an important role in determining the sensitivity of tumor cells to chemotherapeutic intervention. Bcl-x(L

ErbB4 increases the proliferation potent
ErbB4 increases the proliferation potential of human lung cancer cells and its blockage can be used as a target for anti-cancer therapy
✍ Alex Starr; Joel Greif; Akiva Vexler; Maia Ashkenazy-Voghera; Valery Gladesh; Ch 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 218 KB 👁 1 views

## Abstract Clinical and experimental data suggest that ErbB‐4, a member of the epidermal growth factor receptor family, may have a role in cancer progression and response to treatment. We found recently, using a retrospective clinical analysis, that expression of ErbB‐4 receptor is correlated with